These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15102095)

  • 1. Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene.
    Orlandi A; Bianchi L; Costanzo A; Campione E; Giusto Spagnoli L; Chimenti S
    J Invest Dermatol; 2004 Apr; 122(4):1037-41. PubMed ID: 15102095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases.
    Bianchi L; Orlandi A; Campione E; Angeloni C; Costanzo A; Spagnoli LG; Chimenti S
    Br J Dermatol; 2004 Jul; 151(1):148-56. PubMed ID: 15270884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tazarotene-induced gene 3 is suppressed in basal cell carcinomas and reversed in vivo by tazarotene application.
    Duvic M; Ni X; Talpur R; Herne K; Schulz C; Sui D; Ward S; Joseph A; Hazarika P
    J Invest Dermatol; 2003 Oct; 121(4):902-9. PubMed ID: 14632211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis.
    So PL; Fujimoto MA; Epstein EH
    Mol Cancer Ther; 2008 May; 7(5):1275-84. PubMed ID: 18483315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tazarotene induces apoptosis in human basal cell carcinoma via activation of caspase-8/t-Bid and the reactive oxygen species-dependent mitochondrial pathway.
    Wu CS; Chen GS; Lin PY; Pan IH; Wang ST; Lin SH; Yu HS; Lin CC
    DNA Cell Biol; 2014 Oct; 33(10):652-66. PubMed ID: 24927175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome.
    Tang JY; Chiou AS; Mackay-Wiggan JM; Aszterbaum M; Chanana AM; Lee W; Lindgren JA; Raphael MA; Thompson BJ; Bickers DR; Epstein EH
    Cancer Prev Res (Phila); 2014 Mar; 7(3):292-9. PubMed ID: 24441673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermoscopic monitoring of tazarotene treatment of superficial basal cell carcinoma.
    Peris K; Ferrari A; Fargnoli MC; Piccolo D; Chimenti S
    Dermatol Surg; 2005 Feb; 31(2):217-20. PubMed ID: 15762218
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of topical tazarotene: a review.
    Talpur R; Cox K; Duvic M
    Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):195-210. PubMed ID: 20213916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tazarotene: the first receptor-selective topical retinoid for the treatment of psoriasis.
    Chandraratna RA
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 3):S12-7. PubMed ID: 9270551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of imiquimod for the expression of Bcl-2, Ki67, p53 and basal cell carcinoma apoptosis.
    Vidal D; Matías-Guiu X; Alomar A
    Br J Dermatol; 2004 Sep; 151(3):656-62. PubMed ID: 15377354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bax/bcl-2: cellular modulator of apoptosis in feline skin and basal cell tumours.
    Madewell BR; Gandour-Edwards R; Edwards BF; Matthews KR; Griffey SM
    J Comp Pathol; 2001; 124(2-3):115-21. PubMed ID: 11222007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of all-trans-retinoic acid, acitretin and tazarotene on apoptosis and Bax/Bcl-2 expressions of human melanoma cells A375 and the significance].
    Ran LW; Tan SS; Wang WJ; Qiu S; Lei XB; Zeng WH
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):972-4, 978. PubMed ID: 16109552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial.
    Brinkhuizen T; Frencken KJ; Nelemans PJ; Hoff ML; Kelleners-Smeets NW; Zur Hausen A; van der Horst MP; Rennspiess D; Winnepenninckx VJ; van Steensel MA; Mosterd K
    J Am Acad Dermatol; 2016 Jul; 75(1):126-34. PubMed ID: 27067393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The garlic-derived organosulfur component ajoene decreases basal cell carcinoma tumor size by inducing apoptosis.
    Tilli CM; Stavast-Kooy AJ; Vuerstaek JD; Thissen MR; Krekels GA; Ramaekers FC; Neumann HA
    Arch Dermatol Res; 2003 Jul; 295(3):117-23. PubMed ID: 12756587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study on the use of topical tazarotene to treat squamous cell carcinoma in situ.
    Bardazzi F; Bianchi F; Parente G; Guareschi E; Landi C
    J Am Acad Dermatol; 2005 Jun; 52(6):1102-4. PubMed ID: 15928641
    [No Abstract]   [Full Text] [Related]  

  • 17. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of bcl-2, bax and p53 protein in the basal cell carcinoma].
    Yan L; Chen M; Yu G
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):179-80. PubMed ID: 11938785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous apoptosis in laryngeal squamous cell carcinoma is independent of bcl-2 and bax protein expression.
    Jäckel MC; Dorudian MA; Marx D; Brinck U; Schauer A; Steiner W
    Cancer; 1999 Feb; 85(3):591-9. PubMed ID: 10091732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis.
    Xu XC; Wong WY; Goldberg L; Baer SC; Wolf JE; Ramsdell WM; Alberts DS; Lippman SM; Lotan R
    Cancer Res; 2001 Jun; 61(11):4306-10. PubMed ID: 11389049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.